NeuroCare.AI Secures $20.8M Funding Boost to Accelerate AI-Driven Healthcare Innovation

NeuroCare.

AI is excited to announce that it has raised $20,800,000 in a recent funding round, a transformative step that will further its mission to revolutionize healthcare through innovative, AI-driven solutions.

At the forefront of healthcare innovation, NeuroCare.AI has consistently empowered providers to deliver superior care by enhancing patient outcomes and streamlining clinical workflows.

This funding injection will accelerate the expansion and enhancement of its robust product suite, including AizaMD, Radiology Report Generation (RRG), RadioView.AI, and NeuroICH.

AizaMD, the ambient clinical documentation tool, automates SOAP notes creation and seamlessly integrates with electronic health records (EHRs), saving providers over 90 minutes daily while increasing revenue by an additional $1,000 per day, all while ensuring precise and optimal coding.

RRG, a voice-enabled solution for radiologists, boosts report generation by 20% daily, alleviating burnout and contributing up to $1 million in annual reimbursement improvements. With RadioView.

AI, healthcare professionals can access high-quality DICOM images on their mobile devices, ensuring flexibility and precision in diagnostics.

Additionally, NeuroICH provides real-time analysis of brain scans, facilitating early stroke detection and rapid diagnosis of intracranial hemorrhage to enable timely interventions. All of NeuroCare.

AI’s solutions are HIPAA-compliant and HiTrust certified, underscoring the company’s unwavering commitment to security and excellence.

The latest round of funding not only affirms the company’s innovative vision but will also fuel further research, development, and global expansion, ultimately setting new benchmarks in efficient, patient-centered care.